Fund HoldingsPivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value
$123.56M
Total Bought
$45.02M
Total Sold
$0
Net Transaction
+$45.02M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
OCULIS HOLDING AG1,737,6962,300,774+563,07829,54143,78435.43%+14,243
ARCUTIS BIOTHERAPEUTICS INC(ARQT)2,120,5082,120,508029,53933,16526.84%+3,626
IO BIOTECH INC864,197864,19707959420.76%+147
VIGIL NEUROSCIENCE INC560,595560,59509539980.81%+45
ZENAS BIOPHARMA INC(ZBIO)736,645736,64506,0335,8194.71%-214
BOLT BIOTHERAPEUTICS INC1,891,4671,891,46701,0217570.61%-265
RALLYBIO CORP2,404,6442,404,64402,3081,5631.26%-745
RECURSION PHARMACEUTICALS IN(RXRX)595,518595,51804,0263,1502.55%-875
BIOAGE LABS INC(BIOA)653,374653,37403,7832,4571.99%-1,326
INOZYME PHARMA INC4,494,8514,494,851012,4514,0903.31%-8,360
VAXCYTE INC(PCVX)703,834710,734+6,90057,61626,83721.72%-30,779
Page 1 of 1